Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenuePayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Convertible Debt (2022)

Historic Convertible Debt for Coya Therapeutics (COYA) over the last 1 years, with Q4 2022 value amounting to $13.0 million.

  • Coya Therapeutics' Convertible Debt changed N/A to $13.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $13.0 million, marking a year-over-year change of. This contributed to the annual value of $13.0 million for FY2022, which is N/A changed from last year.
  • As of Q4 2022, Coya Therapeutics' Convertible Debt stood at $13.0 million.
  • Coya Therapeutics' Convertible Debt's 5-year high stood at $13.0 million during Q4 2022, with a 5-year trough of $13.0 million in Q4 2022.